Cargando…

Reciprocal Interactions between Fibroblast and Pancreatic Neuroendocrine Tumor Cells: Putative Impact of the Tumor Microenvironment

SIMPLE SUMMARY: Treatment of pancreatic neuroendocrine neoplasms (PNEN) is challenging since a subset of patients will have a metastatic disease at diagnosis and/or will experience resistance to the treatment. Whether the tumor microenvironment (TME) may represent a therapeutic target of interest in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuny, Thomas, van Koetsveld, Peter M., Mondielli, Grégoire, Dogan, Fadime, de Herder, Wouter W., Barlier, Anne, Hofland, Leo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321816/
https://www.ncbi.nlm.nih.gov/pubmed/35884539
http://dx.doi.org/10.3390/cancers14143481
Descripción
Sumario:SIMPLE SUMMARY: Treatment of pancreatic neuroendocrine neoplasms (PNEN) is challenging since a subset of patients will have a metastatic disease at diagnosis and/or will experience resistance to the treatment. Whether the tumor microenvironment (TME) may represent a therapeutic target of interest in these tumors, remains to be elucidated. Our aim was to investigate the role played by stromal fibroblasts (namely, HPF and HFL-1) over the growth of human PNEN cell lines BON-1 and QGP-1, and vice versa. We confirmed a reciprocal stimulatory effect of HPF and HFL-1 over the growth of BON-1 and QGP-1, and the other way around. Likewise, the number of BON-1/QGP-1 colonies and the migration potency of both cell lines, significantly increased in presence of fibroblast-conditioned medium. Finally, the mTOR inhibitor, everolimus, mitigated the fibroblast-induced stimulatory effect over BON-1/QGP-1 cell lines, suggesting that fibroblasts, as an actor of the TME of PNEN, is a promising therapeutic target. ABSTRACT: Introduction: Pancreatic neuroendocrine neoplasms (PNENs) present with a fibrotic stroma that constitutes the tumor microenvironment (TME). The role played by stromal fibroblasts in the growth of PNENs and their sensitivity to the mTOR inhibitor RAD001 has not yet been established. Methods: We investigated reciprocal interactions between (1) human PNEN cell lines (BON-1/QGP-1) or primary cultures of human ileal neuroendocrine neoplasm (iNEN) or PNEN and (2) human fibroblast cell lines (HPF/HFL-1). Proliferation was assessed in transwell (tw) co-culture or in the presence of serum-free conditioned media (cm), with and without RAD001. Colony formation and migration of BON-1/QGP-1 were evaluated upon incubation with HPFcm. Results: Proliferation of BON-1 and QGP-1 increased in the presence of HFL-1cm, HPFcm, HFL-1tw and HPFtw (BON-1: +46–70% and QGP-1: +42–55%, p < 0.001 vs. controls) and HPFcm significantly increased the number of BON-1 or QGP-1 colonies (p < 0.05). This stimulatory effect was reversed in the presence of RAD001. Likewise, proliferation of human iNEN and PNEN primary cultures increased in the presence of HFL-1 or HPF. Reciprocally, BON-1cm and BONtw stimulated the proliferation of HPF (+90 ± 61% and +55 ± 47%, respectively, p < 0.001 vs. controls), an effect less pronounced with QGP-1cm or QGPtw (+19 to +27%, p < 0.05 vs. controls). Finally, a higher migration potential for BON-1 and QGP-1 was found in the presence of HPFcm (p < 0.001 vs. controls). Conclusions: Fibroblasts in the TME of PNENs represent a target of interest, the stimulatory effect of which over PNENs is mitigated by the mTOR inhibitor everolimus.